View More Recent Stories

Jun 18, 2024 06:09AM AstraZeneca (AZN) announces CAPItello-290 Phase III trial did not meet endpoints
Jun 17, 2024 07:03AM AstraZeneca (AZN) announces IMFINZI plus chemotherapy approved in the US
Jun 10, 2024 06:03AM AstraZeneca (AZN): TAGRISSO granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
Jun 10, 2024 04:36AM AstraZeneca (AZN) announces Tagrisso granted FDA Priority Review for patients with unresectable, Stage III EGFR-mutated lung cancer
View More Recent Stories